| A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). (NCT04729751) | Mirum Pharmaceuticals, Inc. | 2021-09-09 |
| Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome (NCT05035030) | Albireo, an Ipsen Company | 2021-09-03 |
| Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome (NCT04674761) | Albireo | 2021-03-19 |
| An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects (NCT03082937) | Albireo | 2017-01-31 |
| FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) (NCT02922751) | Arbor Research Collaborative for Health | 2016-11-16 |
| An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome (NCT02117713) | Mirum Pharmaceuticals, Inc. | 2015-03-16 |
| Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome (NCT02057692) | Mirum Pharmaceuticals, Inc. | 2014-11-24 |
| Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS) (NCT02160782) | Mirum Pharmaceuticals, Inc. | 2014-10-28 |
| Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease (NCT02131623) | Mirum Pharmaceuticals, Inc. | 2014-07-01 |
| An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS) (NCT02047318) | Mirum Pharmaceuticals, Inc. | 2013-12-20 |
| Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome (NCT01903460) | Mirum Pharmaceuticals, Inc. | 2013-08-01 |
| A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 (NCT02963077) | Albireo | 2013-07-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) (NCT00571272) | Arbor Research Collaborative for Health | 2007-11-30 |
| Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review (NCT01515631) | Stanford University | 2007-04-01 |
| Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease (NCT00007033) | National Center for Research Resources (NCRR) | 2000-10-01 |
| Positional Cloning of the Gene(s) Responsible for Alagille Syndrome (NCT00001642) | National Human Genome Research Institute (NHGRI) | 1997-05-01 |
| A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS) (NCT04530994) | Mirum Pharmaceuticals, Inc. | |